K. Fujita

Papers

1

Total Citations

7

H-Index

1

About

K. Fujita is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for upper tract urothelial carcinoma (UTUC). His major contributions center on comparative effectiveness research, systematically evaluating open, laparoscopic, and robotic radical nephroureterectomy (RNU) techniques. In a landmark 2023 multicenter, multinational study, Fujita led a propensity score-matched analysis of over 1,400 patients, demonstrating that robotic RNU offers superior perioperative outcomes—including reduced blood loss and shorter hospital stays—while maintaining equivalent oncological efficacy to open and laparoscopic approaches. This work, which has already garnered 7 citations, provides crucial evidence guiding surgical decision-making for UTUC. Fujita’s research is distinguished by its rigorous methodology and international collaboration, establishing benchmarks for minimally invasive urologic oncology. His findings directly impact clinical practice by clarifying the trade-offs between surgical approaches, helping surgeons and patients choose the optimal treatment strategy. Through his comparative analyses, Fujita continues to advance the evidence base for robotic surgery in complex urologic malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Comparing oncological and perioperative outcomes of open versus laparoscopic versus robotic radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A multicenter, multinational, propensity score-matched analysis
7 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 24

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago